CA3035151A1 - Genetically modified bacteria stably expressing il-10 and insulin - Google Patents

Info

Publication number

CA3035151A1

CA3035151A1 CA3035151A CA3035151A CA3035151A1 CA 3035151 A1 CA3035151 A1 CA 3035151A1 CA 3035151 A CA3035151 A CA 3035151A CA 3035151 A CA3035151 A CA 3035151A CA 3035151 A1 CA3035151 A1 CA 3035151A1

Authority

CA

Canada

Prior art keywords

lab

nucleic acid

exogenous nucleic

gene

acid encoding

Prior art date

2016-09-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 241000894006 Bacteria Species 0.000 title claims abstract description 63
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims description 50
• 102000004877 Insulin Human genes 0.000 title claims description 25
• 108090001061 Insulin Proteins 0.000 title claims description 25
• 229940125396 insulin Drugs 0.000 title claims description 25
• 239000000203 mixture Substances 0.000 claims abstract description 141
• 238000000034 method Methods 0.000 claims abstract description 139
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 133
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims abstract description 124
• 108010076181 Proinsulin Proteins 0.000 claims abstract description 117
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 115
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 115
• 238000011282 treatment Methods 0.000 claims abstract description 89
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims abstract description 49
• 235000014897 Streptococcus lactis Nutrition 0.000 claims abstract description 37
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 22
• 239000004310 lactic acid Substances 0.000 claims abstract description 11
• 235000014655 lactic acid Nutrition 0.000 claims abstract description 11
• 241000194035 Lactococcus lactis Species 0.000 claims abstract 4
• 108090000623 proteins and genes Proteins 0.000 claims description 167
• 230000014509 gene expression Effects 0.000 claims description 106
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 54
• 108091029795 Intergenic region Proteins 0.000 claims description 53
• 239000008103 glucose Substances 0.000 claims description 51
• 210000004369 blood Anatomy 0.000 claims description 50
• 239000008280 blood Substances 0.000 claims description 50
• 230000028327 secretion Effects 0.000 claims description 50
• 101001033233 Homo sapiens Interleukin-10 Proteins 0.000 claims description 47
• 102000052620 human IL10 Human genes 0.000 claims description 45
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 41
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 41
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 41
• 101150036652 GAPB gene Proteins 0.000 claims description 40
• 101150115929 Usp45 gene Proteins 0.000 claims description 33
• 101100010747 Escherichia coli (strain K12) epd gene Proteins 0.000 claims description 29
• 101150098454 GAPA2 gene Proteins 0.000 claims description 29
• 101100335749 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) gap gene Proteins 0.000 claims description 29
• 101150045855 rpmD gene Proteins 0.000 claims description 29
• 101150072314 thyA gene Proteins 0.000 claims description 22
• 108020003272 trehalose-phosphatase Proteins 0.000 claims description 22
• 239000002773 nucleotide Substances 0.000 claims description 21
• 125000003729 nucleotide group Chemical group 0.000 claims description 21
• 230000001105 regulatory effect Effects 0.000 claims description 18
• 101100427060 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) thyA1 gene Proteins 0.000 claims description 17
• 101100153154 Escherichia phage T5 thy gene Proteins 0.000 claims description 17
• 101100313751 Rickettsia conorii (strain ATCC VR-613 / Malish 7) thyX gene Proteins 0.000 claims description 17
• 101150095512 otsB gene Proteins 0.000 claims description 17
• 150000001413 amino acids Chemical group 0.000 claims description 12
• 239000003814 drug Substances 0.000 claims description 12
• VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 claims description 11
• 108010075254 C-Peptide Proteins 0.000 claims description 11
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 10
• 108010011224 Trehalose 6-phosphate phosphorylase Proteins 0.000 claims description 9
• 238000002360 preparation method Methods 0.000 claims description 9
• 102100023941 G-protein-signaling modulator 2 Human genes 0.000 claims description 7
• 101710130585 Secreted 45 kDa protein Proteins 0.000 claims description 7
• GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 6
• 229950002610 otelixizumab Drugs 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 241000588724 Escherichia coli Species 0.000 claims description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
• 235000004279 alanine Nutrition 0.000 claims description 3
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 2
• 230000002779 inactivation Effects 0.000 claims 2
• 101100394073 Caenorhabditis elegans hil-1 gene Proteins 0.000 claims 1
• 101150090658 PINS gene Proteins 0.000 claims 1
• 244000005700 microbiome Species 0.000 abstract description 144
• 108090000174 Interleukin-10 Proteins 0.000 abstract description 136
• 102000003814 Interleukin-10 Human genes 0.000 abstract description 134
• 108090000765 processed proteins & peptides Proteins 0.000 abstract description 122
• 102000004196 processed proteins & peptides Human genes 0.000 abstract description 118
• 229920001184 polypeptide Polymers 0.000 abstract description 116
• 239000000427 antigen Substances 0.000 abstract description 103
• 108091007433 antigens Proteins 0.000 abstract description 96
• 102000036639 antigens Human genes 0.000 abstract description 93
• 238000002560 therapeutic procedure Methods 0.000 abstract description 56
• 239000008194 pharmaceutical composition Substances 0.000 abstract description 41
• 230000000813 microbial effect Effects 0.000 abstract description 15
• 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 10
• 230000000975 bioactive effect Effects 0.000 abstract description 7
• 210000003578 bacterial chromosome Anatomy 0.000 abstract description 5
• 244000057717 Streptococcus lactis Species 0.000 description 117
• 241000699670 Mus sp. Species 0.000 description 106
• 229940076144 interleukin-10 Drugs 0.000 description 73
• 210000004027 cell Anatomy 0.000 description 66
• 206010012601 diabetes mellitus Diseases 0.000 description 63
• 210000001744 T-lymphocyte Anatomy 0.000 description 60
• 238000002648 combination therapy Methods 0.000 description 56
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 53
• 239000002552 dosage form Substances 0.000 description 50
• 230000001580 bacterial effect Effects 0.000 description 41
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 35
• 201000010099 disease Diseases 0.000 description 34
• 108010078791 Carrier Proteins Proteins 0.000 description 31
• 101000904754 Homo sapiens G-protein-signaling modulator 2 Proteins 0.000 description 30
• 238000009472 formulation Methods 0.000 description 30
• 210000003289 regulatory T cell Anatomy 0.000 description 30
• 230000006870 function Effects 0.000 description 26
• 239000013612 plasmid Substances 0.000 description 25
• 239000003826 tablet Substances 0.000 description 24
• 108091028043 Nucleic acid sequence Proteins 0.000 description 23
• 150000001875 compounds Chemical class 0.000 description 23
• 230000001225 therapeutic effect Effects 0.000 description 23
• 102000016607 Diphtheria Toxin Human genes 0.000 description 22
• 108010053187 Diphtheria Toxin Proteins 0.000 description 22
• 238000003780 insertion Methods 0.000 description 22
• 230000037431 insertion Effects 0.000 description 22
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 21
• 108091022930 Glutamate decarboxylase Proteins 0.000 description 21
• 102000008214 Glutamate decarboxylase Human genes 0.000 description 21
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 21
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 21
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 21
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 21
• 102000049884 human GPSM2 Human genes 0.000 description 21
• 108020004705 Codon Proteins 0.000 description 20
• 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 20
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 20
• 239000002775 capsule Substances 0.000 description 20
• 230000000694 effects Effects 0.000 description 20
• 230000001717 pathogenic effect Effects 0.000 description 20
• 102000004169 proteins and genes Human genes 0.000 description 20
• 239000007788 liquid Substances 0.000 description 19
• 230000003248 secreting effect Effects 0.000 description 19
• 230000001332 colony forming effect Effects 0.000 description 18
• 239000012634 fragment Substances 0.000 description 18
• 210000004877 mucosa Anatomy 0.000 description 18
• 230000035772 mutation Effects 0.000 description 18
• 210000000496 pancreas Anatomy 0.000 description 18
• 125000003275 alpha amino acid group Chemical group 0.000 description 17
• 230000002068 genetic effect Effects 0.000 description 17
• 235000018102 proteins Nutrition 0.000 description 17
• 108700026244 Open Reading Frames Proteins 0.000 description 16
• 210000000349 chromosome Anatomy 0.000 description 16
• 239000000546 pharmaceutical excipient Substances 0.000 description 16
• 238000012360 testing method Methods 0.000 description 16
• 239000003937 drug carrier Substances 0.000 description 15
• 230000002519 immonomodulatory effect Effects 0.000 description 15
• 241000194036 Lactococcus Species 0.000 description 14
• 230000002354 daily effect Effects 0.000 description 14
• 244000000010 microbial pathogen Species 0.000 description 14
• -1 amino acid salt Chemical class 0.000 description 13
• 239000003795 chemical substances by application Substances 0.000 description 13
• 230000000875 corresponding effect Effects 0.000 description 13
• 235000016709 nutrition Nutrition 0.000 description 13
• 239000000725 suspension Substances 0.000 description 13
• 238000000692 Student's t-test Methods 0.000 description 12
• 235000001014 amino acid Nutrition 0.000 description 12
• 239000012636 effector Substances 0.000 description 12
• 238000005259 measurement Methods 0.000 description 12
• 239000000843 powder Substances 0.000 description 12
• 239000003381 stabilizer Substances 0.000 description 12
• 238000012353 t test Methods 0.000 description 12
• 241000699666 Mus <mouse, genus> Species 0.000 description 11
• 229940024606 amino acid Drugs 0.000 description 11
• 239000008187 granular material Substances 0.000 description 11
• 230000006801 homologous recombination Effects 0.000 description 11
• 238000002744 homologous recombination Methods 0.000 description 11
• 230000010354 integration Effects 0.000 description 11
• 210000005259 peripheral blood Anatomy 0.000 description 11
• 239000011886 peripheral blood Substances 0.000 description 11
• 108700039887 Essential Genes Proteins 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
• 241000186660 Lactobacillus Species 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
• 108010044226 Class 8 Receptor-Like Protein Tyrosine Phosphatases Proteins 0.000 description 9
• 102000006449 Class 8 Receptor-Like Protein Tyrosine Phosphatases Human genes 0.000 description 9
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
• 230000001939 inductive effect Effects 0.000 description 9
• 238000007912 intraperitoneal administration Methods 0.000 description 9
• 235000000346 sugar Nutrition 0.000 description 9
• 206010061818 Disease progression Diseases 0.000 description 8
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 8
• 241001465754 Metazoa Species 0.000 description 8
• 239000000227 bioadhesive Substances 0.000 description 8
• 230000005750 disease progression Effects 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• 210000001165 lymph node Anatomy 0.000 description 8
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
• 229920000642 polymer Polymers 0.000 description 8
• 230000035755 proliferation Effects 0.000 description 8
• 238000009097 single-agent therapy Methods 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 101710135915 50S ribosomal protein L30 Proteins 0.000 description 7
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
• 238000013270 controlled release Methods 0.000 description 7
• 238000012377 drug delivery Methods 0.000 description 7
• 238000000684 flow cytometry Methods 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 230000001965 increasing effect Effects 0.000 description 7
• 230000006698 induction Effects 0.000 description 7
• 239000004615 ingredient Substances 0.000 description 7
• 230000000977 initiatory effect Effects 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 229940039696 lactobacillus Drugs 0.000 description 7
• 239000002609 medium Substances 0.000 description 7
• 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 7
• 101710096438 DNA-binding protein Proteins 0.000 description 6
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 6
• 229920002125 Sokalan® Polymers 0.000 description 6
• 229920002472 Starch Polymers 0.000 description 6
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 6
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
• 239000004480 active ingredient Substances 0.000 description 6
• 239000000969 carrier Substances 0.000 description 6
• 238000000576 coating method Methods 0.000 description 6
• 238000012217 deletion Methods 0.000 description 6
• 230000037430 deletion Effects 0.000 description 6
• 235000013305 food Nutrition 0.000 description 6
• 239000000499 gel Substances 0.000 description 6
• 230000001506 immunosuppresive effect Effects 0.000 description 6
• 239000006186 oral dosage form Substances 0.000 description 6
• 239000003755 preservative agent Substances 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• 235000019698 starch Nutrition 0.000 description 6
• 239000008107 starch Substances 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 230000004083 survival effect Effects 0.000 description 6
• 238000012546 transfer Methods 0.000 description 6
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
• 241000193830 Bacillus <bacterium> Species 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
• 241000192125 Firmicutes Species 0.000 description 5
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 5
• 206010018473 Glycosuria Diseases 0.000 description 5
• 102000001554 Hemoglobins Human genes 0.000 description 5
• 108010054147 Hemoglobins Proteins 0.000 description 5
• 101001082060 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 3 Proteins 0.000 description 5
• 244000199866 Lactobacillus casei Species 0.000 description 5
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 108091081024 Start codon Proteins 0.000 description 5
• 206010051083 Therapy responder Diseases 0.000 description 5
• 238000009825 accumulation Methods 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 150000001720 carbohydrates Chemical class 0.000 description 5
• 235000014633 carbohydrates Nutrition 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 238000004090 dissolution Methods 0.000 description 5
• 239000000975 dye Substances 0.000 description 5
• 239000000796 flavoring agent Substances 0.000 description 5
• 238000004108 freeze drying Methods 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 230000035780 glucosuria Effects 0.000 description 5
• 230000002641 glycemic effect Effects 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 239000003906 humectant Substances 0.000 description 5
• 239000008101 lactose Substances 0.000 description 5
• 238000001325 log-rank test Methods 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 239000002324 mouth wash Substances 0.000 description 5
• 235000015097 nutrients Nutrition 0.000 description 5
• 230000002035 prolonged effect Effects 0.000 description 5
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 5
• 230000002459 sustained effect Effects 0.000 description 5
• 239000003765 sweetening agent Substances 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• LABSPYBHMPDTEL-JGZVXCDNSA-N trehalose-6-phosphate Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](COP(O)(O)=O)O1 LABSPYBHMPDTEL-JGZVXCDNSA-N 0.000 description 5
• 239000013598 vector Substances 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 208000023275 Autoimmune disease Diseases 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 101100299477 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbI gene Proteins 0.000 description 4
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
• 241000194033 Enterococcus Species 0.000 description 4
• 102100036255 Glucose-6-phosphatase 2 Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 238000012313 Kruskal-Wallis test Methods 0.000 description 4
• 235000013958 Lactobacillus casei Nutrition 0.000 description 4
• 241000186851 Lactobacillus mali Species 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 229930195725 Mannitol Natural products 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
• 229930006000 Sucrose Natural products 0.000 description 4
• 108010022394 Threonine synthase Proteins 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000006472 autoimmune response Effects 0.000 description 4
• 244000052616 bacterial pathogen Species 0.000 description 4
• 239000011230 binding agent Substances 0.000 description 4
• 229940077731 carbohydrate nutrients Drugs 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 239000011248 coating agent Substances 0.000 description 4
• 210000001072 colon Anatomy 0.000 description 4
• 239000003086 colorant Substances 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 229960003276 erythromycin Drugs 0.000 description 4
• 235000019441 ethanol Nutrition 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 235000003599 food sweetener Nutrition 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 235000011187 glycerol Nutrition 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 230000001900 immune effect Effects 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 210000002602 induced regulatory T cell Anatomy 0.000 description 4
• 230000008595 infiltration Effects 0.000 description 4
• 238000001764 infiltration Methods 0.000 description 4
• 210000000936 intestine Anatomy 0.000 description 4
• 239000007937 lozenge Substances 0.000 description 4
• 235000019359 magnesium stearate Nutrition 0.000 description 4
• 239000000594 mannitol Substances 0.000 description 4
• 235000010355 mannitol Nutrition 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 239000003921 oil Substances 0.000 description 4
• 235000019198 oils Nutrition 0.000 description 4
• 238000007410 oral glucose tolerance test Methods 0.000 description 4
• 239000008188 pellet Substances 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 101150118630 ptsI gene Proteins 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 210000002784 stomach Anatomy 0.000 description 4
• 239000005720 sucrose Substances 0.000 description 4
• 150000008163 sugars Chemical class 0.000 description 4
• 229950010127 teplizumab Drugs 0.000 description 4
• 230000014616 translation Effects 0.000 description 4
• 210000002700 urine Anatomy 0.000 description 4
• 229940088594 vitamin Drugs 0.000 description 4
• 229930003231 vitamin Natural products 0.000 description 4
• 235000013343 vitamin Nutrition 0.000 description 4
• 239000011782 vitamin Substances 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
• 241000186000 Bifidobacterium Species 0.000 description 3
• 102100032912 CD44 antigen Human genes 0.000 description 3
• 241000206600 Carnobacterium maltaromaticum Species 0.000 description 3
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 102100027581 Forkhead box protein P3 Human genes 0.000 description 3
• 108010010803 Gelatin Proteins 0.000 description 3
• 102100035857 Glutamate decarboxylase 2 Human genes 0.000 description 3
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 3
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 3
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 3
• 101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 description 3
• 241001134659 Lactobacillus curvatus Species 0.000 description 3
• 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 3
• 241000186612 Lactobacillus sakei Species 0.000 description 3
• 241000186869 Lactobacillus salivarius Species 0.000 description 3
• 101100363550 Leptospira borgpetersenii serovar Hardjo-bovis (strain L550) rpsE2 gene Proteins 0.000 description 3
• 101100254826 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) rps5 gene Proteins 0.000 description 3
• 229920000881 Modified starch Polymers 0.000 description 3
• 108091000080 Phosphotransferase Proteins 0.000 description 3
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 3
• TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
• 240000008042 Zea mays Species 0.000 description 3
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 230000005784 autoimmunity Effects 0.000 description 3
• 239000002585 base Substances 0.000 description 3
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 230000003915 cell function Effects 0.000 description 3
• 150000001773 cellobioses Chemical class 0.000 description 3
• 230000036755 cellular response Effects 0.000 description 3
• 238000011284 combination treatment Methods 0.000 description 3
• 235000005822 corn Nutrition 0.000 description 3
• 230000002596 correlated effect Effects 0.000 description 3
• 229960004397 cyclophosphamide Drugs 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 230000003111 delayed effect Effects 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• 230000001904 diabetogenic effect Effects 0.000 description 3
• 238000003745 diagnosis Methods 0.000 description 3
• 230000003292 diminished effect Effects 0.000 description 3
• 239000006185 dispersion Substances 0.000 description 3
• 210000003162 effector t lymphocyte Anatomy 0.000 description 3
• 235000013355 food flavoring agent Nutrition 0.000 description 3
• 229960002737 fructose Drugs 0.000 description 3
• 239000008273 gelatin Substances 0.000 description 3
• 229920000159 gelatin Polymers 0.000 description 3
• 235000019322 gelatine Nutrition 0.000 description 3
• 235000011852 gelatine desserts Nutrition 0.000 description 3
• 238000012224 gene deletion Methods 0.000 description 3
• 238000007446 glucose tolerance test Methods 0.000 description 3
• 108010017007 glucose-regulated proteins Proteins 0.000 description 3
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
• 230000006058 immune tolerance Effects 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 210000004153 islets of langerhan Anatomy 0.000 description 3
• 229940017800 lactobacillus casei Drugs 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 239000000314 lubricant Substances 0.000 description 3
• HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
• 235000010755 mineral Nutrition 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 230000003472 neutralizing effect Effects 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 210000004923 pancreatic tissue Anatomy 0.000 description 3
• 230000008844 regulatory mechanism Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 101150027173 rpsE gene Proteins 0.000 description 3
• 101150036132 rpsG gene Proteins 0.000 description 3
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 210000004988 splenocyte Anatomy 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000004094 surface-active agent Substances 0.000 description 3
• 239000006188 syrup Substances 0.000 description 3
• 235000020357 syrup Nutrition 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• 238000011285 therapeutic regimen Methods 0.000 description 3
• 229940104230 thymidine Drugs 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 235000010447 xylitol Nutrition 0.000 description 3
• 239000000811 xylitol Substances 0.000 description 3
• HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
• 229960002675 xylitol Drugs 0.000 description 3
• GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• 239000005995 Aluminium silicate Substances 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 102000010792 Chromogranin A Human genes 0.000 description 2
• 108010038447 Chromogranin A Proteins 0.000 description 2
• 229920002261 Corn starch Polymers 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 229920003134 Eudragit® polymer Polymers 0.000 description 2
• 229930091371 Fructose Natural products 0.000 description 2
• 239000005715 Fructose Substances 0.000 description 2
• 101150014889 Gad1 gene Proteins 0.000 description 2
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
• 101710172364 Glucose-6-phosphatase 2 Proteins 0.000 description 2
• 102100035902 Glutamate decarboxylase 1 Human genes 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
• 101000930907 Homo sapiens Glucose-6-phosphatase 2 Proteins 0.000 description 2
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 2
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 2
• 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
• 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
• 241000186840 Lactobacillus fermentum Species 0.000 description 2
• 241000186839 Lactobacillus fructivorans Species 0.000 description 2
• 241000183331 Lactobacillus paracasei subsp. tolerans Species 0.000 description 2
• 240000006024 Lactobacillus plantarum Species 0.000 description 2
• 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
• 244000246386 Mentha pulegium Species 0.000 description 2
• 235000016257 Mentha pulegium Nutrition 0.000 description 2
• 235000004357 Mentha x piperita Nutrition 0.000 description 2
• 208000032234 No therapeutic response Diseases 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 240000007594 Oryza sativa Species 0.000 description 2
• 235000007164 Oryza sativa Nutrition 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 102000004590 Peripherins Human genes 0.000 description 2
• 108010003081 Peripherins Proteins 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 102100021688 Rho guanine nucleotide exchange factor 5 Human genes 0.000 description 2
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
• 235000019485 Safflower oil Nutrition 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 241000194017 Streptococcus Species 0.000 description 2
• 241000194049 Streptococcus equinus Species 0.000 description 2
• 235000019486 Sunflower oil Nutrition 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• 102000004248 Zinc Transporter 8 Human genes 0.000 description 2
• 108090000702 Zinc Transporter 8 Proteins 0.000 description 2
• 108091006550 Zinc transporters Proteins 0.000 description 2
• 238000002679 ablation Methods 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 235000012211 aluminium silicate Nutrition 0.000 description 2
• 210000000612 antigen-presenting cell Anatomy 0.000 description 2
• 239000008365 aqueous carrier Substances 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 239000007900 aqueous suspension Substances 0.000 description 2
• 230000001363 autoimmune Effects 0.000 description 2
• 239000003833 bile salt Substances 0.000 description 2
• 229940093761 bile salts Drugs 0.000 description 2
• 230000027455 binding Effects 0.000 description 2
• 230000035587 bioadhesion Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 239000000090 biomarker Substances 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 238000009534 blood test Methods 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
• 230000000112 colonic effect Effects 0.000 description 2
• 238000007906 compression Methods 0.000 description 2
• 230000006835 compression Effects 0.000 description 2
• 239000013256 coordination polymer Substances 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 239000000551 dentifrice Substances 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 238000005538 encapsulation Methods 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000003925 fat Substances 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
• 230000037433 frameshift Effects 0.000 description 2
• 230000002496 gastric effect Effects 0.000 description 2
• 150000002334 glycols Chemical class 0.000 description 2
• 235000001050 hortel pimenta Nutrition 0.000 description 2
• 201000001421 hyperglycemia Diseases 0.000 description 2
• 210000003405 ileum Anatomy 0.000 description 2
• 230000003832 immune regulation Effects 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 238000011081 inoculation Methods 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 229960000367 inositol Drugs 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
• 239000008206 lipophilic material Substances 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 108020004999 messenger RNA Proteins 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
• 239000004005 microsphere Substances 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 210000004400 mucous membrane Anatomy 0.000 description 2
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
• 239000004006 olive oil Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 210000005047 peripherin Anatomy 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 229920005862 polyol Polymers 0.000 description 2
• 150000003077 polyols Chemical class 0.000 description 2
• 230000000750 progressive effect Effects 0.000 description 2
• 238000001243 protein synthesis Methods 0.000 description 2
• 230000002685 pulmonary effect Effects 0.000 description 2
• LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 235000009566 rice Nutrition 0.000 description 2
• 235000019204 saccharin Nutrition 0.000 description 2
• 229940081974 saccharin Drugs 0.000 description 2
• 235000005713 safflower oil Nutrition 0.000 description 2
• 239000003813 safflower oil Substances 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 210000000813 small intestine Anatomy 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 210000004989 spleen cell Anatomy 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000002600 sunflower oil Substances 0.000 description 2
• 230000000153 supplemental effect Effects 0.000 description 2
• 238000013268 sustained release Methods 0.000 description 2
• 239000012730 sustained-release form Substances 0.000 description 2
• 238000011287 therapeutic dose Methods 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• 230000001052 transient effect Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 238000011269 treatment regimen Methods 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 230000003442 weekly effect Effects 0.000 description 2
• NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 239000004382 Amylase Substances 0.000 description 1
• 108010011485 Aspartame Proteins 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 241000193815 Atopobium minutum Species 0.000 description 1
• 241000193836 Atopobium rimae Species 0.000 description 1
• 101100301559 Bacillus anthracis repS gene Proteins 0.000 description 1
• 108090000363 Bacterial Luciferases Proteins 0.000 description 1
• 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
• 241000186014 Bifidobacterium angulatum Species 0.000 description 1
• 241000186016 Bifidobacterium bifidum Species 0.000 description 1
• 241000186011 Bifidobacterium catenulatum Species 0.000 description 1
• 241001608472 Bifidobacterium longum Species 0.000 description 1
• 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
• 102000008203 CTLA-4 Antigen Human genes 0.000 description 1
• 229940045513 CTLA4 antagonist Drugs 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 241000206593 Carnobacterium divergens Species 0.000 description 1
• GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 244000037364 Cinnamomum aromaticum Species 0.000 description 1
• 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
• 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 101100247969 Clostridium saccharobutylicum regA gene Proteins 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
• 229930182827 D-tryptophan Natural products 0.000 description 1
• QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 206010011968 Decreased immune responsiveness Diseases 0.000 description 1
• 208000034423 Delivery Diseases 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 241001430190 Eggerthia catenaformis Species 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
• 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
• 241000701867 Enterobacteria phage T7 Species 0.000 description 1
• 241000207358 Enterococcus alcedinis Species 0.000 description 1
• 241000032329 Enterococcus aquimarinus Species 0.000 description 1
• 241000580502 Enterococcus asini Species 0.000 description 1
• 241001468179 Enterococcus avium Species 0.000 description 1
• 241001315449 Enterococcus caccae Species 0.000 description 1
• 241000784223 Enterococcus camelliae Species 0.000 description 1
• 241001304086 Enterococcus canintestini Species 0.000 description 1
• 241001584862 Enterococcus canis Species 0.000 description 1
• 241000178336 Enterococcus cecorum Species 0.000 description 1
• 241000194028 Enterococcus columbae Species 0.000 description 1
• 241001343527 Enterococcus devriesei Species 0.000 description 1
• 241000178337 Enterococcus dispar Species 0.000 description 1
• 241000520130 Enterococcus durans Species 0.000 description 1
• 241001462445 Enterococcus eurekensis Species 0.000 description 1
• 241000194032 Enterococcus faecalis Species 0.000 description 1
• 241000194031 Enterococcus faecium Species 0.000 description 1
• 241000194030 Enterococcus gallinarum Species 0.000 description 1
• 241000320082 Enterococcus gilvus Species 0.000 description 1
• 241000009793 Enterococcus haemoperoxidus Species 0.000 description 1
• 241001059855 Enterococcus hermanniensis Species 0.000 description 1
• 241000194029 Enterococcus hirae Species 0.000 description 1
• 241001026002 Enterococcus italicus Species 0.000 description 1
• 241001106597 Enterococcus lactis Species 0.000 description 1
• 241001462444 Enterococcus lemanii Species 0.000 description 1
• 241001235140 Enterococcus malodoratus Species 0.000 description 1
• 241000009792 Enterococcus moraviensis Species 0.000 description 1
• 241000520134 Enterococcus mundtii Species 0.000 description 1
• 241000750231 Enterococcus olivae Species 0.000 description 1
• 241001672794 Enterococcus phoeniculicola Species 0.000 description 1
• 241000783253 Enterococcus plantarum Species 0.000 description 1
• 241000178338 Enterococcus pseudoavium Species 0.000 description 1
• 241000828250 Enterococcus quebecensis Species 0.000 description 1
• 241001235138 Enterococcus raffinosus Species 0.000 description 1
• 241001617376 Enterococcus ratti Species 0.000 description 1
• 241000268619 Enterococcus rivorum Species 0.000 description 1
• 241000238765 Enterococcus rotai Species 0.000 description 1
• 241000134765 Enterococcus saccharolyticus Species 0.000 description 1
• 241000339361 Enterococcus silesiacus Species 0.000 description 1
• 241000339090 Enterococcus termitis Species 0.000 description 1
• 241001026958 Enterococcus thailandicus Species 0.000 description 1
• 241000828248 Enterococcus ureasiticus Species 0.000 description 1
• 241000637011 Enterococcus ureilyticus Species 0.000 description 1
• 241000223163 Enterococcus viikkiensis Species 0.000 description 1
• 241000169378 Enterococcus villorum Species 0.000 description 1
• 241000962428 Enterococcus xiangfangensis Species 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 101100412434 Escherichia coli (strain K12) repB gene Proteins 0.000 description 1
• 244000004281 Eucalyptus maculata Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
• 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 1
• 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 description 1
• 241000186777 Fructobacillus fructosus Species 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 101150112743 HSPA5 gene Proteins 0.000 description 1
• 101100223318 Homo sapiens GAD2 gene Proteins 0.000 description 1
• 101500025336 Homo sapiens Heparin-binding EGF-like growth factor Proteins 0.000 description 1
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 1
• 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 108091023242 Internal transcribed spacer Proteins 0.000 description 1
• 241000186778 Kandleria vitulina Species 0.000 description 1
• 241000170280 Kluyveromyces sp. Species 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 241000186717 Lactobacillus acetotolerans Species 0.000 description 1
• 240000001046 Lactobacillus acidophilus Species 0.000 description 1
• 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
• 241000186716 Lactobacillus agilis Species 0.000 description 1
• 241001507052 Lactobacillus algidus Species 0.000 description 1
• 241000186715 Lactobacillus alimentarius Species 0.000 description 1
• 241001647783 Lactobacillus amylolyticus Species 0.000 description 1
• 241000186714 Lactobacillus amylophilus Species 0.000 description 1
• 241000186713 Lactobacillus amylovorus Species 0.000 description 1
• 241000186711 Lactobacillus aviarius Species 0.000 description 1
• 241001324879 Lactobacillus aviarius subsp. araffinosus Species 0.000 description 1
• 241001324861 Lactobacillus aviarius subsp. aviarius Species 0.000 description 1
• 240000001929 Lactobacillus brevis Species 0.000 description 1
• 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
• 241000186679 Lactobacillus buchneri Species 0.000 description 1
• 241001468197 Lactobacillus collinoides Species 0.000 description 1
• 241000186842 Lactobacillus coryniformis Species 0.000 description 1
• 241000202368 Lactobacillus coryniformis subsp. coryniformis Species 0.000 description 1
• 241000202367 Lactobacillus coryniformis subsp. torquens Species 0.000 description 1
• 241000218492 Lactobacillus crispatus Species 0.000 description 1
• 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
• 241001647786 Lactobacillus delbrueckii subsp. delbrueckii Species 0.000 description 1
• 241000186841 Lactobacillus farciminis Species 0.000 description 1
• 241000015236 Lactobacillus fornicalis Species 0.000 description 1
• 241000509544 Lactobacillus gallinarum Species 0.000 description 1
• 241000186606 Lactobacillus gasseri Species 0.000 description 1
• 241000866684 Lactobacillus graminis Species 0.000 description 1
• 241000383778 Lactobacillus hamsteri Species 0.000 description 1
• 240000002605 Lactobacillus helveticus Species 0.000 description 1
• 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
• 241001147748 Lactobacillus heterohiochii Species 0.000 description 1
• 241000186685 Lactobacillus hilgardii Species 0.000 description 1
• 241001468190 Lactobacillus homohiochii Species 0.000 description 1
• 241001324870 Lactobacillus iners Species 0.000 description 1
• 241001640457 Lactobacillus intestinalis Species 0.000 description 1
• 241001561398 Lactobacillus jensenii Species 0.000 description 1
• 241001468157 Lactobacillus johnsonii Species 0.000 description 1
• 241000108055 Lactobacillus kefiranofaciens Species 0.000 description 1
• 241001407640 Lactobacillus kefiranofaciens subsp. kefirgranum Species 0.000 description 1
• 241001468191 Lactobacillus kefiri Species 0.000 description 1
• 241001339775 Lactobacillus kunkeei Species 0.000 description 1
• 241001134654 Lactobacillus leichmannii Species 0.000 description 1
• 241000520745 Lactobacillus lindneri Species 0.000 description 1
• 241000751214 Lactobacillus malefermentans Species 0.000 description 1
• 241000016642 Lactobacillus manihotivorans Species 0.000 description 1
• 241000394636 Lactobacillus mucosae Species 0.000 description 1
• 241000186871 Lactobacillus murinus Species 0.000 description 1
• 241001635183 Lactobacillus nagelii Species 0.000 description 1
• 241000186784 Lactobacillus oris Species 0.000 description 1
• 241000216456 Lactobacillus panis Species 0.000 description 1
• 241001643453 Lactobacillus parabuchneri Species 0.000 description 1
• 241000186605 Lactobacillus paracasei Species 0.000 description 1
• 241000218587 Lactobacillus paracasei subsp. paracasei Species 0.000 description 1
• 241001643449 Lactobacillus parakefiri Species 0.000 description 1
• 241001647418 Lactobacillus paralimentarius Species 0.000 description 1
• 241000866650 Lactobacillus paraplantarum Species 0.000 description 1
• 241000186684 Lactobacillus pentosus Species 0.000 description 1
• 241001448603 Lactobacillus perolens Species 0.000 description 1
• 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
• 241001495404 Lactobacillus pontis Species 0.000 description 1
• 241000186604 Lactobacillus reuteri Species 0.000 description 1
• 241001438705 Lactobacillus rogosae Species 0.000 description 1
• 241000186870 Lactobacillus ruminis Species 0.000 description 1
• 241001582342 Lactobacillus sakei subsp. sakei Species 0.000 description 1
• 241000186868 Lactobacillus sanfranciscensis Species 0.000 description 1
• 235000013864 Lactobacillus sanfrancisco Nutrition 0.000 description 1
• 241000186867 Lactobacillus sharpeae Species 0.000 description 1
• 241001643448 Lactobacillus suebicus Species 0.000 description 1
• 241000751212 Lactobacillus vaccinostercus Species 0.000 description 1
• 241000577554 Lactobacillus zeae Species 0.000 description 1
• 241000194040 Lactococcus garvieae Species 0.000 description 1
• 235000013471 Lactococcus lactis subsp hordniae Nutrition 0.000 description 1
• 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
• 241001183079 Lactococcus lactis subsp. hordniae Species 0.000 description 1
• 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 1
• 241000194039 Lactococcus piscium Species 0.000 description 1
• 241000194037 Lactococcus raffinolactis Species 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 229920002774 Maltodextrin Polymers 0.000 description 1
• 239000005913 Maltodextrin Substances 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 238000000585 Mann–Whitney U test Methods 0.000 description 1
• 235000006679 Mentha X verticillata Nutrition 0.000 description 1
• 244000024873 Mentha crispa Species 0.000 description 1
• 235000014749 Mentha crispa Nutrition 0.000 description 1
• 235000002899 Mentha suaveolens Nutrition 0.000 description 1
• 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
• BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 241001095209 Monascus sp. (in: Fungi) Species 0.000 description 1
• 229920000715 Mucilage Polymers 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 240000009023 Myrrhis odorata Species 0.000 description 1
• 235000007265 Myrrhis odorata Nutrition 0.000 description 1
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
• 238000011789 NOD SCID mouse Methods 0.000 description 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
• 241000927555 Olsenella uli Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 235000019482 Palm oil Nutrition 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 241000235061 Pichia sp. Species 0.000 description 1
• 235000012550 Pimpinella anisum Nutrition 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 208000004880 Polyuria Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 230000021839 RNA stabilization Effects 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 101150078442 RPL5 gene Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108010082913 S-layer proteins Proteins 0.000 description 1
• 101100111629 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR2 gene Proteins 0.000 description 1
• 241000235088 Saccharomyces sp. Species 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• 229920002385 Sodium hyaluronate Polymers 0.000 description 1
• GDVNLLJNADMLLR-BBRMVZONSA-N Spergualin Chemical compound NCCCNCCCCNC(=O)[C@H](O)NC(=O)C[C@@H](O)CCCCN=C(N)N GDVNLLJNADMLLR-BBRMVZONSA-N 0.000 description 1
• JBVZQDJNGFOSNX-UHFFFAOYSA-N Spergualin Natural products NCCCNCCCCNC(=O)C(O)NC(=O)CC(O)CCCCNC(=CN)N JBVZQDJNGFOSNX-UHFFFAOYSA-N 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 101710145796 Staphylokinase Proteins 0.000 description 1
• 241000193985 Streptococcus agalactiae Species 0.000 description 1
• 101100114425 Streptococcus agalactiae copG gene Proteins 0.000 description 1
• 241000194008 Streptococcus anginosus Species 0.000 description 1
• 241001291896 Streptococcus constellatus Species 0.000 description 1
• 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
• 235000014969 Streptococcus diacetilactis Nutrition 0.000 description 1
• 241000194042 Streptococcus dysgalactiae Species 0.000 description 1
• 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 description 1
• 241000194056 Streptococcus iniae Species 0.000 description 1
• 241000194046 Streptococcus intermedius Species 0.000 description 1
• 241001464947 Streptococcus milleri Species 0.000 description 1
• 241001134658 Streptococcus mitis Species 0.000 description 1
• 241000194025 Streptococcus oralis Species 0.000 description 1
• 241000782300 Streptococcus oralis subsp. tigurinus Species 0.000 description 1
• 241000193991 Streptococcus parasanguinis Species 0.000 description 1
• 241000960362 Streptococcus peroris Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241001403829 Streptococcus pseudopneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 241000194052 Streptococcus ratti Species 0.000 description 1
• 241000194024 Streptococcus salivarius Species 0.000 description 1
• 241000194023 Streptococcus sanguinis Species 0.000 description 1
• 241000193987 Streptococcus sobrinus Species 0.000 description 1
• 241000194021 Streptococcus suis Species 0.000 description 1
• 241000194020 Streptococcus thermophilus Species 0.000 description 1
• 241000194054 Streptococcus uberis Species 0.000 description 1
• 241000194051 Streptococcus vestibularis Species 0.000 description 1
• 241001312524 Streptococcus viridans Species 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
• 241001235136 Tetragenococcus solitarius Species 0.000 description 1
• 210000004241 Th2 cell Anatomy 0.000 description 1
• JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 1
• 102000005497 Thymidylate Synthase Human genes 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
• 229930003779 Vitamin B12 Natural products 0.000 description 1
• 229930003268 Vitamin C Natural products 0.000 description 1
• 229930003316 Vitamin D Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 229930003448 Vitamin K Natural products 0.000 description 1
• 241000186675 Weissella confusa Species 0.000 description 1
• 241000186838 Weissella halotolerans Species 0.000 description 1
• 241000186837 Weissella kandleri Species 0.000 description 1
• 241000186864 Weissella minor Species 0.000 description 1
• 241000186882 Weissella viridescens Species 0.000 description 1
• 239000005862 Whey Substances 0.000 description 1
• 102000007544 Whey Proteins Human genes 0.000 description 1
• 108010046377 Whey Proteins Proteins 0.000 description 1
• 241000490645 Yarrowia sp. Species 0.000 description 1
• 241001030170 Zygosaccharomyces sp. Species 0.000 description 1
• YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
• 229960005164 acesulfame Drugs 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000000274 adsorptive effect Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 230000002776 aggregation Effects 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 238000000540 analysis of variance Methods 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000001745 anti-biotin effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000013011 aqueous formulation Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 235000019568 aromas Nutrition 0.000 description 1
• 239000000605 aspartame Substances 0.000 description 1
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• 229960003438 aspartame Drugs 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 239000000440 bentonite Substances 0.000 description 1
• 229910000278 bentonite Inorganic materials 0.000 description 1
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
• 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
• 229940004120 bifidobacterium infantis Drugs 0.000 description 1
• 229940009291 bifidobacterium longum Drugs 0.000 description 1
• 239000003613 bile acid Substances 0.000 description 1
• 238000010170 biological method Methods 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 235000020299 breve Nutrition 0.000 description 1
• 210000005178 buccal mucosa Anatomy 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 239000000828 canola oil Substances 0.000 description 1
• 235000019519 canola oil Nutrition 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 235000013339 cereals Nutrition 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 235000017803 cinnamon Nutrition 0.000 description 1
• 229960003405 ciprofloxacin Drugs 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
• MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 235000009508 confectionery Nutrition 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 238000011262 co‐therapy Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 235000013365 dairy product Nutrition 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 239000004815 dispersion polymer Substances 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 229940032049 enterococcus faecalis Drugs 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 239000010685 fatty oil Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 229940091249 fluoride supplement Drugs 0.000 description 1
• 229960000304 folic acid Drugs 0.000 description 1
• 235000019152 folic acid Nutrition 0.000 description 1
• 239000011724 folic acid Substances 0.000 description 1
• 231100000221 frame shift mutation induction Toxicity 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 210000004051 gastric juice Anatomy 0.000 description 1
• 210000001156 gastric mucosa Anatomy 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 235000003869 genetically modified organism Nutrition 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 238000005469 granulation Methods 0.000 description 1
• 230000003179 granulation Effects 0.000 description 1
• 101150028578 grp78 gene Proteins 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 235000019534 high fructose corn syrup Nutrition 0.000 description 1
• 230000036571 hydration Effects 0.000 description 1
• 238000006703 hydration reaction Methods 0.000 description 1
• 230000003345 hyperglycaemic effect Effects 0.000 description 1
• 230000004046 hyporesponsiveness Effects 0.000 description 1
• 230000008629 immune suppression Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 201000006747 infectious mononucleosis Diseases 0.000 description 1
• 238000010212 intracellular staining Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• MHKWSJBPFXBFMX-UHFFFAOYSA-N iron magnesium Chemical compound [Mg].[Fe] MHKWSJBPFXBFMX-UHFFFAOYSA-N 0.000 description 1
• 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
• 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
• 229940012969 lactobacillus fermentum Drugs 0.000 description 1
• 229940054346 lactobacillus helveticus Drugs 0.000 description 1
• 239000006356 lactobacillus kefiranofaciens Substances 0.000 description 1
• 229940072205 lactobacillus plantarum Drugs 0.000 description 1
• 229940001882 lactobacillus reuteri Drugs 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 210000000207 lymphocyte subset Anatomy 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 229940035034 maltodextrin Drugs 0.000 description 1
• WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
• 235000012054 meals Nutrition 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 229940057917 medium chain triglycerides Drugs 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• 229940041616 menthol Drugs 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
• 229940012189 methyl orange Drugs 0.000 description 1
• 229960001047 methyl salicylate Drugs 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 230000003020 moisturizing effect Effects 0.000 description 1
• 235000013923 monosodium glutamate Nutrition 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 229940051866 mouthwash Drugs 0.000 description 1
• 230000003232 mucoadhesive effect Effects 0.000 description 1
• 238000007837 multiplex assay Methods 0.000 description 1
• 229960003816 muromonab-cd3 Drugs 0.000 description 1
• 229960003512 nicotinic acid Drugs 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 235000006180 nutrition needs Nutrition 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Chemical class 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000008203 oral pharmaceutical composition Substances 0.000 description 1
• 239000007935 oral tablet Substances 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 239000003346 palm kernel oil Substances 0.000 description 1
• 235000019865 palm kernel oil Nutrition 0.000 description 1
• 239000002540 palm oil Substances 0.000 description 1
• 238000004091 panning Methods 0.000 description 1
• 229940055726 pantothenic acid Drugs 0.000 description 1
• 235000019161 pantothenic acid Nutrition 0.000 description 1
• 239000011713 pantothenic acid Substances 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 239000002953 phosphate buffered saline Substances 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 150000004804 polysaccharides Chemical class 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 238000009258 post-therapy Methods 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 235000008160 pyridoxine Nutrition 0.000 description 1
• 239000011677 pyridoxine Substances 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
• 230000007420 reactivation Effects 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 101150044854 repA gene Proteins 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000000979 retarding effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 235000019192 riboflavin Nutrition 0.000 description 1
• 229960002477 riboflavin Drugs 0.000 description 1
• 239000002151 riboflavin Substances 0.000 description 1
• 101150083684 rplE gene Proteins 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000017550 sodium carbonate Nutrition 0.000 description 1
• 229940073490 sodium glutamate Drugs 0.000 description 1
• 229940010747 sodium hyaluronate Drugs 0.000 description 1
• 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
• 229910052938 sodium sulfate Inorganic materials 0.000 description 1
• 235000011152 sodium sulphate Nutrition 0.000 description 1
• YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000003393 splenic effect Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 229940115920 streptococcus dysgalactiae Drugs 0.000 description 1
• 229940115921 streptococcus equinus Drugs 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 229940076156 streptococcus pyogenes Drugs 0.000 description 1
• 229940115922 streptococcus uberis Drugs 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229960001967 tacrolimus Drugs 0.000 description 1
• QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 239000000892 thaumatin Substances 0.000 description 1
• 235000010436 thaumatin Nutrition 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• 235000019157 thiamine Nutrition 0.000 description 1
• 229960003495 thiamine Drugs 0.000 description 1
• 239000011721 thiamine Substances 0.000 description 1
• KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 230000024664 tolerance induction Effects 0.000 description 1
• 230000003614 tolerogenic effect Effects 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 101150089952 trePP gene Proteins 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
• 230000029069 type 2 immune response Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 230000009677 vaginal delivery Effects 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 229950004393 visilizumab Drugs 0.000 description 1
• 235000019155 vitamin A Nutrition 0.000 description 1
• 239000011719 vitamin A Substances 0.000 description 1
• 235000019163 vitamin B12 Nutrition 0.000 description 1
• 239000011715 vitamin B12 Substances 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 150000003710 vitamin D derivatives Chemical class 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 235000019168 vitamin K Nutrition 0.000 description 1
• 239000011712 vitamin K Substances 0.000 description 1
• 150000003721 vitamin K derivatives Chemical class 0.000 description 1
• 229940045997 vitamin a Drugs 0.000 description 1
• 229940011671 vitamin b6 Drugs 0.000 description 1
• 229940046008 vitamin d Drugs 0.000 description 1
• 229940046010 vitamin k Drugs 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 238000012070 whole genome sequencing analysis Methods 0.000 description 1